Klotho Neurosciences (NASDAQ:KLTO) Shares Down 7.7% – Should You Sell?

Klotho Neurosciences, Inc. (NASDAQ:KLTO)’s share price fell 7.7% during mid-day trading on Monday . The stock traded as low as $0.16 and last traded at $0.16. 43,508 shares were traded during trading, a decline of 93% from the average session volume of 632,243 shares. The stock had previously closed at $0.17.

Klotho Neurosciences Stock Down 7.7 %

The firm’s fifty day simple moving average is $0.26 and its two-hundred day simple moving average is $0.38.

Klotho Neurosciences (NASDAQ:KLTO) last issued its quarterly earnings data on Monday, March 31st. The company reported ($0.07) earnings per share for the quarter.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Klotho Neurosciences stock. Geode Capital Management LLC boosted its stake in Klotho Neurosciences, Inc. (NASDAQ:KLTO) by 122.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 140,606 shares of the company’s stock after purchasing an additional 77,372 shares during the period. Geode Capital Management LLC owned about 0.52% of Klotho Neurosciences worth $68,000 at the end of the most recent quarter. Institutional investors own 20.07% of the company’s stock.

About Klotho Neurosciences

Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.